Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone on 01753 627777.
HCP experience of using cabozantinib + nivolumab to treat patients with aRCC
Renal Cell Carcinoma
Video
03:18
Hear from Prof. Laurence Albiges and Prof. James Larkin sharing their experience of using Cabo+Nivo to treat patients with aRCC.
CBZ-UK-000344 | November 2024
